Photo from Sandro Porceddu/LinkedIn
Sep 1, 2024, 14:50
Sandro Porceddu: Even low dose cisplatin has an impact on sensorineural hearing loss
Sandro Porceddu, Director of the Department of Radiation Oncology at Peter MacCallum Cancer Centre, shared a post on LinkedIn:
“In another stellar presentation, ANZHNCS ASM Laurelie Wishart presented our findings of hearing outcomes in the randomised TROG 12.01 low risk HPV oropharyngeal cancer study confirming that even low dose cisplatin has an impact on sensorineural hearing loss (albeit substantially less than historical data with high dose cisplatin).
Even patients receiving low dose cisplatin should be evaluated and counseled regarding hearing loss.”
Source: Sandro Porceddu/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27